BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Cell Therapy
    • COVID-19
    • CAR-T
    • Cord Blood
  • Exosomes
  • Interviews
  • News
    • Press Releases
    • Job Posts
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » Stem Cells » HSCs

Hematopoietic Stem Cells (HSCs)

The Future of Stem Cell Therapeutics – Balancing Safety and Efficacy

January 20, 2021 By Cade Hildreth (CEO) 4 Comments

Safety Chart | The Future of Stem Cell Therapeutics – Balancing Safety and Efficacy

What do we know of the safety and efficacy of stem cell therapeutics? Over 50 years have passed since the discovery of hematopoietic stem cells (bone marrow transplantation to cure diseases such as leukemia), over 20 years since the discovery of human embryonic stem cells (hESC), and 15 years since the discovery of induced pluripotent stem cells (iPS cells). There are now thousands of stem cell trials underway in clinics worldwide.

Despite this experience, what do we actually know about the safety and efficacy of stem cell therapeutics? [Read more…]

Filed Under: HSCs, iPS Cells, MSCs, Neural Stem Cells, Stem Cells Tagged With: direct cell reprogramming, stem cell therapy

The French Blood Agency announces agreement with TreeFrog Therapeutics to scale-up manufacturing of iPS-derived hematopoietic stem cell transplants

December 2, 2020 By Cade Hildreth (CEO)

TreeFrog iPSC
TreeFrog Therapeutics will apply its proprietary technology for the mass-production of stem cell therapies to the world-first single-step protocol allowing the differentiation of human induced pluripotent stem cells (iPSCs) into fully functional human hematopoietic stem cells (HSCs). Resulting off-the-shelf universal HSC grafts could reduce costs and waiting times for patients in need of a bone marrow transplant.

Bordeaux, France – November, 17th, 2020 —The French Blood Agency (EFS) and TreeFrog Therapeutics announce a partnership to advance the mass-production of iPSC-derived HSC transplants based on a patented differentiation protocol developed by the EFS (UMR S938), the Institute for Radioprotection and Nuclear Safety (IRSN) and Sorbonne University[1]. [Read more…]

Filed Under: HSCs, iPS Cells, Press Releases, Stem Cell News Tagged With: iPS cells

Do You Know The 5 Types Of Stem Cells?

November 30, 2020 By Cade Hildreth (CEO)

Type of Stem Cell | Do You Know The 5 Types Of Stem Cells

As you start to learn about stem cells, one of the most common questions to have is, “What types of stem cells exist?” There is not an agreed-upon number of stem cell types, because one can classify stem cells either by differentiation potential (what they can turn into) or by origin (from where they are sourced). This post is dedicated to explaining the five types of stem cells, based on differentiation potential. [Read more…]

Filed Under: HSCs, iPS Cells, MSCs, Neural Stem Cells, Stem Cells

Stem Cell Transplants: What To Know About This Life-Saving Procedure

October 1, 2020 By Cade Hildreth (CEO)

Feature | Stem Cell Transplants: Types and Procedures

Stem cell transplants are a medical procedure in which which stem cells are transplanted into an injured or diseased recipient. This procedure can either involve stem cells derived from one’s self or stem cells  derived from a healthy donor.

In this article:

  1. Types of Stem Cell Transplant in Treating Diseases
  2. Advantages of Stem Cell Transplant in Treating Diseases
  3. Stem Cell Collection
  4. Stem Cell Transplant Procedure
  5. Stem Cell Transplant Recovery
  6. Diseases Treated with Stem Cell Transplant
  7. Stem Cell Transplant Success Rate

[Read more…]

Filed Under: HSCs, Stem Cells

Who Is CryoHoldco? Latin America’s Largest Cord Blood Bank

August 21, 2020 By Cade Hildreth (CEO)

CryoHoldco is a stem cell bank holding company that is the market leader in Latin America and one of the top 10 largest cord blood banks in the world. By the end of 2020, CryoHoldco will be seven times larger than any other stem cell bank in Latin America and will have 275,000 stem cell units in storage.

[Read more…]

Filed Under: Cord Blood, HSCs, MSCs, Stem Cells Tagged With: cord blood, CryoHoldco, news

  • 1
  • 2
  • 3
  • …
  • 32
  • Next Page »

Let’s Get Social

  • Facebook
  • Twitter
  • Instagram
  • Pinterest
  • LinkedIn

Nanocellect

Marathon Products

Menu
  • Blog
  • Stem Cell News
    • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Top Rated Products

  • US Cord Blood and Cord Tissue Storage Rates Rates of U.S. Cord Blood and Cord Tissue Storage - Historical and Projected
    Rated 0 out of 5
    $197
  • Job Posting on BioInformant Job Posting on BioInformant.com - Your Perfect Hire Is In Our Audience
    Rated 0 out of 5
    $297
  • BioInformant Audience Reach BioInformant's Audience with Your Press Announcement
    Rated 0 out of 5
    $397 $297

Featured Posts

Stem cell conferences

The Complete Guide To Virtual Stem Cell Conferences in 2021

CO.DON AG

The New CO.DON Plant for the EU-approved Advanced Therapy Cartilage Regeneration Treatment Sets a Milestone in Cell Therapy for Commercial Manufacturing

Safety Chart | The Future of Stem Cell Therapeutics – Balancing Safety and Efficacy

The Future of Stem Cell Therapeutics – Balancing Safety and Efficacy

My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2021 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: [email protected] | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.